Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are shown in bold with a green bullet. See more at Help:Related changes.
List of abbreviations (help):
- D
- Edit made at Wikidata
- r
- Edit flagged by ORES
- N
- New page
- m
- Minor edit
- b
- Bot edit
- (±123)
- Page byte size change
- Temporarily watched page
9 June 2024
- diffhist m Dostarlimab 15:16 −4 Arjayay talk contribs (Duplicate word removed)
- diffhist m Food and Drug Administration 08:06 −272 Meters talk contribs (Reverted edit by Militiaman27 (talk) to last version by 24.114.86.104) Tag: Rollback
- diffhist Food and Drug Administration 07:49 +272 Militiaman27 talk contribs Tags: Reverted Visual edit
- diffhist Larotrectinib 04:45 −192 Boghog talk contribs (consistent citation formatting)
8 June 2024
- diffhist Ribociclib 20:42 +121 Whywhenwhohow talk contribs (update ref, templates)
- diffhist Dostarlimab 18:17 −291 Boghog talk contribs (consistent citation formatting)
- diffhist Dostarlimab 06:16 +1,439 Lfstevens talk contribs (→Medical uses: colorectal) Tag: Visual edit
- diffhist m Dostarlimab 06:05 +1 Lfstevens talk contribs (→Solid tumors) Tag: Visual edit
- diffhist Dostarlimab 06:04 −1,073 Lfstevens talk contribs (→Medical uses: ce, reorg) Tag: Visual edit
- diffhist Dostarlimab 05:52 +181 Lfstevens talk contribs (Filled in 0 bare reference(s) with reFill 2)
7 June 2024
- diffhist m Lymphatic system 07:42 +44 SimLibrarian talk contribs (lang tag use (MOS:LANG), periods only for complete-sentence image captions (MOS:CAPFRAG), fix red See Also link, dash style (MOS:DASH)) Tag: Visual edit
6 June 2024
- diffhist Food and Drug Administration 22:32 +53 24.114.86.104 talk (→History: Clarity) Tags: Mobile edit Mobile web edit
- diffhist Mirvetuximab soravtansine 17:00 −60 Marbletan talk contribs (no longer a stub)
- diffhist Mogamulizumab 17:00 −60 Marbletan talk contribs (no longer a stub)
- diffhist Trilaciclib 16:57 −18 Marbletan talk contribs (no longer a stub)
5 June 2024
- diffhist m Momelotinib 17:55 +1 Mr. X 235528 talk contribs
- diffhist Rituximab 17:54 +39 Ward20 talk contribs (→Chronic fatigue syndrome: change name to agree with article nomenclature)
- diffhist m Larotrectinib 06:01 +23 MKumaru talk contribs (Added continuous flow chemistry wiki link ot the word) Tag: Visual edit
- diffhist m Larotrectinib 05:58 +773 MKumaru talk contribs (Added flow chemistry to the article) Tag: Visual edit
4 June 2024
- diffhist m Cancer immunotherapy 15:21 +212 M.D. Shahinyan talk contribs (→Types and categories) Tag: Visual edit
- diffhist Lorlatinib 03:34 +186 Whywhenwhohow talk contribs (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5) Tag: IABotManagementConsole [1.3]
- diffhist Lorlatinib 02:55 +265 Whywhenwhohow talk contribs (add ref)
- diffhist Lorlatinib 02:52 +2,897 Whywhenwhohow talk contribs (Rescuing 14 sources and tagging 0 as dead.) #IABot (v2.0.9.5) Tag: IABotManagementConsole [1.3]
- diffhist m Lorlatinib 02:49 +23 Whywhenwhohow talk contribs (script-assisted date audit and style fixes per MOS:NUM)
- diffhist Lorlatinib 02:49 +1,855 Whywhenwhohow talk contribs (update infobox, description, effects uses, refs, links, templates; move text; ce)
- diffhist Cell (biology) 00:48 +1 Sonicsuns talk contribs (→Prokaryotic cells: Added a comma)
3 June 2024
- diffhist m Dostarlimab 17:14 +1 Jautism talk contribs (added a space.) Tags: Visual edit Mobile edit Mobile web edit
- diffhist m Dostarlimab 17:13 −5 Jautism talk contribs (Avelumab and durvalumab were described as PD-1 inhibitors, they are not, they are PD-L1 inhibitors. PD-1 inhibitors include pembrolizumab and Nivolumab.) Tags: Visual edit Mobile edit Mobile web edit
- diffhist Tarlatamab 16:45 −60 Marbletan talk contribs (no longer a stub)
- diffhist Lorlatinib 12:23 −25 Noxoug1 talk contribs (copy edit) Tag: Visual edit
- diffhist Lorlatinib 12:22 +371 Noxoug1 talk contribs (→Clinical studies: CROWN study) Tag: Visual edit
- diffhist Lorlatinib 12:20 +348 Noxoug1 talk contribs (→Clinical studies: CROWN study) Tag: Visual edit
- diffhist Lorlatinib 12:19 +322 Noxoug1 talk contribs (→Clinical studies: CROWN study) Tag: Visual edit
- diffhist m Receptor tyrosine kinase 07:46 +4 Kku talk contribs (link negative feedback)
- diffhist m Interleukin 2 07:40 +4 Kku talk contribs (link negative feedback)
- diffhist m Everolimus 07:38 +4 Kku talk contribs (link negative feedback)